145 related articles for article (PubMed ID: 28679349)
1. Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial.
Ohguri T; Harima Y; Imada H; Sakurai H; Ohno T; Hiraki Y; Tuji K; Tanaka M; Terashima H
Int J Hyperthermia; 2018 Jun; 34(4):461-468. PubMed ID: 28679349
[TBL] [Abstract][Full Text] [Related]
2. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer.
Harima Y; Ohguri T; Imada H; Sakurai H; Ohno T; Hiraki Y; Tuji K; Tanaka M; Terashima H
Int J Hyperthermia; 2016 Nov; 32(7):801-8. PubMed ID: 27418208
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia.
Franckena M; Fatehi D; de Bruijne M; Canters RA; van Norden Y; Mens JW; van Rhoon GC; van der Zee J
Eur J Cancer; 2009 Jul; 45(11):1969-78. PubMed ID: 19361982
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia.
Kroesen M; Mulder HT; van Holthe JML; Aangeenbrug AA; Mens JWM; van Doorn HC; Paulides MM; Oomen-de Hoop E; Vernhout RM; Lutgens LC; van Rhoon GC; Franckena M
Radiother Oncol; 2019 Nov; 140():150-158. PubMed ID: 31302345
[TBL] [Abstract][Full Text] [Related]
5. Definitive radiotherapy plus regional hyperthermia for high-risk and very high-risk prostate carcinoma: Thermal parameters correlated with biochemical relapse-free survival.
Yahara K; Ohguri T; Yamaguchi S; Imada H; Narisada H; Ota S; Tomura K; Sakagami M; Fujimoto N; Korogi Y
Int J Hyperthermia; 2015; 31(6):600-8. PubMed ID: 26287946
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
7. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy--a phase III study.
Zolciak-Siwinska A; Piotrkowicz N; Jonska-Gmyrek J; Nicke-Psikuta M; Michalski W; Kawczyńska M; Bijok M; Bujko K
Radiother Oncol; 2013 Nov; 109(2):194-9. PubMed ID: 23684588
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy combined with deep regional hyperthermia in elderly and frail patients with muscle-invasive bladder cancer: quality analysis of hyperthermia and impact on clinical results.
Ademaj A; Puric E; Marder D; Timm O; Kern T; Hälg RA; Rogers S; Riesterer O
Int J Hyperthermia; 2023; 40(1):2275540. PubMed ID: 37932002
[No Abstract] [Full Text] [Related]
9. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.
Franckena M; Stalpers LJ; Koper PC; Wiggenraad RG; Hoogenraad WJ; van Dijk JD; Wárlám-Rodenhuis CC; Jobsen JJ; van Rhoon GC; van der Zee J
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1176-82. PubMed ID: 17881144
[TBL] [Abstract][Full Text] [Related]
10. Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial.
Maluta S; Schaffer M; Pioli F; Dall'oglio S; Pasetto S; Schaffer PM; Weber B; Giri MG
Strahlenther Onkol; 2011 Oct; 187(10):619-25. PubMed ID: 21932025
[TBL] [Abstract][Full Text] [Related]
11. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z
Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314
[TBL] [Abstract][Full Text] [Related]
12. Chemoradiotherapy with hyperthermia versus chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis.
Yea JW; Park JW; Oh SA; Park J
Int J Hyperthermia; 2021; 38(1):1333-1340. PubMed ID: 34477028
[TBL] [Abstract][Full Text] [Related]
13. Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum.
Maluta S; Romano M; Dall'oglio S; Genna M; Oliani C; Pioli F; Gabbani M; Marciai N; Palazzi M
Int J Hyperthermia; 2010; 26(2):108-17. PubMed ID: 20146565
[TBL] [Abstract][Full Text] [Related]
14. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group.
van der Zee J; González González D; van Rhoon GC; van Dijk JD; van Putten WL; Hart AA
Lancet; 2000 Apr; 355(9210):1119-25. PubMed ID: 10791373
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
Makino H; Kato H; Furui T; Morishige K; Kanematsu M
J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
[TBL] [Abstract][Full Text] [Related]
16. Clinical implementation of hyperthermia treatment planning guided steering: A cross over trial to assess its current contribution to treatment quality.
Franckena M; Canters R; Termorshuizen F; Van Der Zee J; Van Rhoon G
Int J Hyperthermia; 2010; 26(2):145-57. PubMed ID: 20146569
[TBL] [Abstract][Full Text] [Related]
17. [When Should We Perform Surgery for N2 Lung Cancer?;Induction Chemoradiotherapy or Surgery for Local Recurrence or Residual Tumor after Definitive Chemoradiotherapy].
Ito H; Nakayama H
Kyobu Geka; 2018 Apr; 71(4):290-299. PubMed ID: 29755103
[TBL] [Abstract][Full Text] [Related]
18. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
[TBL] [Abstract][Full Text] [Related]
19. Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation.
Heijkoop ST; van Doorn HC; Stalpers LJ; Boere IA; van der Velden J; Franckena M; Westermann AM
Int J Hyperthermia; 2014 Feb; 30(1):6-10. PubMed ID: 24156619
[TBL] [Abstract][Full Text] [Related]
20. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast.
Kapp DS; Cox RS
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):887-99. PubMed ID: 7591899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
